Monday, 17 February 2014: 9:45 AM-11:15 AM
Columbus CD (Hyatt Regency Chicago)The worlds aging population requires the development of new treatment strategies for diseased, defective, or damaged tissues. Since donor material is often not available, artificial tissue needs to be developed for these purposes. Therefore, there is a need for smart materials that can be used to replace and repair tissues to be developed. With better tissue engineering possibilities becoming available, improved methods to visualise the fate and effects of these implants are essential and need to be examined. Tissue engineering and regenerative medicine (TERM) is a multidisciplinary field where scientists need to cut across traditional fields of study. It unites researchers from industry and academia with expertise in material choice, cell biology, and clinical translation to successfully design and clinically implement engineered tissue. This symposium presents the results of research collaborations across Europe and between Europe and the U.S.
Louise Byrne, European Commission, Research Executive Agency
François Willekens, European Commission, Research Executive Agency